Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Psoriatic arthritis
•
General Rheumatology
•
Dermatology
•
Primary Care
Would you continue TNF-inhibitor in a patient with psoriatic arthritis who has had multiple nonmelanoma skin cancers requiring Mohs surgery?
Related Questions
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
How do you counsel patients on the risks and benefits of an IL-23 agent versus an IL-17A or IL-17A/F agent?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
How would you approach management of a young male patient with discoid lupus who has had minimal response to hydroxychloroquine (and subtherapeutic whole blood levels) who continues to use tobacco products?
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
What circumstances would drive you to consider using an oral IL-23 inhibitor over parenteral options for the management of psoriasis and/or psoriatic arthritis?
How would you manage active psoriasis and psoriatic arthritis in patient on Rituximab and prednisone for MPO positive vasculitis?
